No Data
Conglin Technology: Conglin Technology 2024 Annual Performance Report Announcement
Conglin Technology 2024 Annual Performance Report Announcement
Conglin Technology (688370.SH): In 2024, the net income is 93.091 million yuan, an increase of 5.35% year-on-year.
On February 25, Gelonghui reported that Conglin Technology (688370.SH) announced its 2024 annual performance forecast. During the reporting period, the company achieved total revenue of 595.2966 million yuan, a decrease of 6.22% compared to the same period last year; the net income attributable to the parent company's owners was 93.091 million yuan, an increase of 5.35% compared to the same period last year; the net income attributable to the parent company's owners, excluding non-recurring gains and losses, was 51.057 million yuan, an increase of 4.46% compared to the same period last year. The net income attributable to the parent company's owners was 93.091 million yuan, compared to 8,836 in the same period last year.
Conglin Environmental Protection to Buy Stake in Oil Processing Firm for 68 Million Yuan
Conglin Technology (688370.SH): Plans to acquire equity in Ronghe Biotech and increase its capital.
On January 7th, Gelonghui announced that Conglin Technology (688370.SH) plans to acquire equity in Guangxi Fusion Biological Energy Technology Co., Ltd. (referred to as "Fusion Bio" or "the symbol company") for 68 million RMB with its own funds and to increase its capital. Specifically, it intends to acquire 21% of the equity held by Xiamen Nuohongsheng Trading Co., Ltd. for 31.5 million RMB; and intends to increase capital in Fusion Bio by 36.5 million RMB, subscribing to an additional registered capital of 36.5 million RMB. After this trade is completed, the registered capital of Fusion Bio will increase to 200 million RMB, and the company will hold.
Jungle Technology Report for the Third Quarter of 2024